Somatic cell reprogramming

Abstract

The present invention relates to methods for reprogramming a somatic cell to pluripotency by administering into the somatic cell at least one or a plurality of potency-determining factors. The invention also relates to pluripotent cell populations obtained using a reprogramming method.

We claim: 
     
         1 . A method of reprogramming primate somatic cells, the method comprising the steps of:
 introducing a plurality of potency-determining factors into the primate somatic cells under conditions sufficient to reprogram the cells, wherein the potency-determining factors comprise Oct-4 and Sox2, and do not comprise c-Myc and Klf4; and   culturing the primate somatic cells under embryonic stem cell culture conditions to obtain pluripotent reprogrammed cells.   
     
     
         2 . The method of  claim 1 , wherein the primate somatic cells are obtained from a post-natal individual. 
     
     
         3 . The method of  claim 1 , wherein the primate somatic cells are obtained by in vitro differentiation of a stem cell. 
     
     
         4 . The method of  claim 1 , wherein the potency-determining factors are introduced to the somatic cells as a reprogramming sequence in which a nucleic acid sequence encoding the potency-determining factor is operably linked to a heterologous promoter. 
     
     
         5 . The method of  claim 1 , wherein the potency-determining factors are Oct-4, Sox2, and at least one of Nanog and Lin28. 
     
     
         6 . The method of  claim 1 , wherein the potency-determining factors are Oct-4 and Sox2. 
     
     
         7 . The method of  claim 1 , wherein the reprogrammed cells (i) express a cell marker selected from the group consisting of Oct-4, SSEA3, SSEA4, Tra-1-60 and Tra-1-81; (ii) exhibit morphology characteristic of pluripotent cells; and (iii) form teratomas when introduced into an immunocompromised animal. 
     
     
         8 . A method of reprogramming primate somatic cells, the method comprising the steps of:
 introducing a plurality of potency-determining factors into the primate somatic cells under conditions sufficient to reprogram the cells, wherein the potency-determining factors comprise Oct-4, Sox2, Nanog, and Lin28; and   culturing the primate somatic cells under embryonic stem cell culture conditions to obtain reprogrammed cells having a higher potency level than the primate somatic cells.